Oral evidence transcript
| Published on: | Monday 13 January 2014 |
|---|---|
| Date: | Wednesday 8 January 2014 |
| Meeting on: | Wednesday 8 January 2014 |
| Part of event segment: | Untitled |
| Document ID: | 152805 |
| Citations: |
|
Committees
Work packages
-
Antimicrobial resistance (AMR)
Wednesday 11 September 2013 - Tuesday 21 October 2014
Witnesses
-
Professor Anthony Kessel, Director, Public Health Strategy, Public Health England, Dr Michael Moore, National Clinical Champion Antibiotic Stewardship, Royal College of General Practitioners, Professor Alison Holmes, Director of Infection Prevention and Control, National Centre for Infection Prevention and Management, Imperial College London, and Dr Susan Hopkins, Chair, Healthcare Associated Infections Working Group, Royal College of Physicians; John Hardcastle, Chief Executive Officer, Novolytics, Dr David McIntosh, Global Scientific Affairs Senior Expert, Novartis, Professor George Lewith, Professor of Health Research, University of Southampton Medical School, and Doris-Ann Williams, Chief Executive, British In Vitro Diagnostics Association